Competing Risks Model in Screening for Preeclampsia by Biophysical and Biochemical Markers at 30-33 Weeks' Gestation

Publisher： Karger

E-ISSN： 1421-9964|36|1|9-17

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.36, Iss.1, 2014-05, pp. : 9-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

By  

Fetal Diagnosis and Therapy, Vol. 33, Iss. 1, 2012-08 ,pp. : 8-15

Karger

Access to resources Recommend Favorite

Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 4, 2014-05 ,pp. : 240-248

Karger

Access to resources Recommend Favorite

Competing Risk Model in Screening for Preeclampsia by Mean Arterial Pressure and Uterine Artery Pulsatility Index at 30-33 Weeks' Gestation

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 1, 2014-06 ,pp. : 18-27

Karger

Access to resources Recommend Favorite

Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11–13 Weeks

By  

Fetal Diagnosis and Therapy, Vol. 29, Iss. 2, 2010-11 ,pp. : 148-154

Karger

Access to resources Recommend Favorite

A Competing Risks Model in Early Screening for Preeclampsia

By  

Fetal Diagnosis and Therapy, Vol. 32, Iss. 3, 2012-07 ,pp. : 171-178

Karger

Access to resources Recommend Favorite